Skip to main
AMWL

AMWL Stock Forecast & Price Target

AMWL Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 0%
Buy 20%
Hold 80%
Sell 0%
Strong Sell 0%

Bulls say

American Well is showing positive signs of successfully reorienting towards its core technology platform solution and higher-quality recurring revenue, with strong quarterly financial results and raised EBITDA guidance. With a scaled physician network and wide range of services, the company is well positioned to gain share in the growing market for telehealth and virtual care. However, there are potential risks associated with the healthcare IT industry, such as government spending cuts and customer losses due to industry consolidation. Nevertheless, we believe American Well is well positioned for growth and organic growth may come in stronger than expected.

Bears say

American Well is facing risks to its growth and valuation if telehealth adoption is slower than expected among consumers, leading to potential delays in investments from health plan clients. However, the company's strong familiarity and positive patient experiences with telehealth indicate a high likelihood of repeat utilization. Additionally, the DHA contract is set to be renewed in summer 2026, and if reinstated, could provide meaningful revenue upside. The company is also focused on shifting its business to a SaaS-based model and divesting non-core assets.

AMWL has been analyzed by 5 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 20% recommend Buy, 80% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Well Corporation and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Well Corporation (AMWL) Forecast

Analysts have given AMWL a Hold based on their latest research and market trends.

According to 5 analysts, AMWL has a Hold consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.30, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.30, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Well Corporation (AMWL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.